Thrombolytics, anticoagulants, and antiplatelet agents

Stroke. 2006 Feb;37(2):312-3. doi: 10.1161/01.STR.0000200560.01068.65. Epub 2006 Jan 12.
No abstract available

Publication types

  • Review

MeSH terms

  • Abciximab
  • Antibodies, Monoclonal / adverse effects
  • Anticoagulants / therapeutic use*
  • Azetidines / therapeutic use
  • Benzylamines / therapeutic use
  • Clinical Trials as Topic
  • Humans
  • Immunoglobulin Fab Fragments / adverse effects
  • Odds Ratio
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Stroke / drug therapy*
  • Thromboembolism / drug therapy
  • Thrombolytic Therapy / methods*

Substances

  • Antibodies, Monoclonal
  • Anticoagulants
  • Azetidines
  • Benzylamines
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • ximelagatran
  • Abciximab